| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/RMV.1900 |
| P698 | PubMed publication ID | 27550835 |
| P50 | author | Subhash Verma | Q57951657 |
| P2093 | author name string | Lei Liu | |
| Roxanne Strahan | |||
| Fang Wei | |||
| Caixia Zhu | |||
| Qiliang Cai | |||
| Niu Qiao | |||
| Jin Gan | |||
| P2860 | cites work | EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication | Q21131571 |
| Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections | Q24298226 | ||
| Molecular recognition of p53 and MDM2 by USP7/HAUSP | Q24304312 | ||
| The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7 | Q24306662 | ||
| RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation | Q24320385 | ||
| Human Cytomegalovirus Infection Causes Degradation of Sp100 Proteins That Suppress Viral Gene Expression | Q24337028 | ||
| Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases | Q24515076 | ||
| Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase | Q24535609 | ||
| Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells | Q24563268 | ||
| The order Herpesvirales | Q24630904 | ||
| Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways | Q26783655 | ||
| Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I | Q26799569 | ||
| The ubiquitin/proteasome system mediates entry and endosomal trafficking of Kaposi's sarcoma-associated herpesvirus in endothelial cells | Q27345534 | ||
| A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses | Q28118543 | ||
| Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection. | Q39230416 | ||
| Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. | Q39300398 | ||
| Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53. | Q39333947 | ||
| Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. | Q39649881 | ||
| Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies | Q39666008 | ||
| Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication. | Q39789708 | ||
| Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene | Q39833667 | ||
| Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway | Q39860632 | ||
| Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. | Q39879529 | ||
| TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1 | Q39949585 | ||
| Herpes simplex virus type 1 regulatory protein ICP0 does not protect cyclins D1 and D3 from degradation during infection | Q39959660 | ||
| Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication | Q40021229 | ||
| Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. | Q40030711 | ||
| Proteasome-dependent, ubiquitin-independent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells | Q40115653 | ||
| Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein | Q40254715 | ||
| Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7. | Q40373883 | ||
| Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination | Q40502162 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1 | Q40607781 | ||
| Human cytomegalovirus protein pp71 induces Daxx SUMOylation | Q41360318 | ||
| A non-canonical ESCRT pathway, including histidine domain phosphotyrosine phosphatase (HD-PTP), is used for down-regulation of virally ubiquitinated MHC class I. | Q41535734 | ||
| Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase η recruitment to DNA damage sites | Q41775152 | ||
| Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription | Q41905953 | ||
| The RING finger domain of Varicella-Zoster virus ORF61p has E3 ubiquitin ligase activity that is essential for efficient autoubiquitination and dispersion of Sp100-containing nuclear bodies | Q41950990 | ||
| SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. | Q41983297 | ||
| Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a) | Q42196349 | ||
| The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity | Q42222047 | ||
| Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection. | Q42231391 | ||
| The Cellular Isopeptidase T Deubiquitinating Enzyme Regulates Kaposi’s Sarcoma-Associated Herpesvirus K7 Degradation | Q50741759 | ||
| What Determines the Specificity and Outcomes of Ubiquitin Signaling? | Q57206327 | ||
| Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection | Q37520106 | ||
| Human viral oncogenesis: a cancer hallmarks analysis | Q37711147 | ||
| Herpesviruses and immunity: the art of evasion | Q37715247 | ||
| Ubiquitin: Same Molecule, Different Degradation Pathways | Q37812727 | ||
| Reading the ubiquitin postal code | Q37950639 | ||
| Human Pathogens and the Host Cell SUMOylation System | Q37954599 | ||
| Regulation of alphaherpesvirus infections by the ICP0 family of proteins | Q38067373 | ||
| Interplay between viruses and host sumoylation pathways | Q38102561 | ||
| SUMO-targeted ubiquitin ligases. | Q38135651 | ||
| Viral manipulation of cellular protein conjugation pathways: The SUMO lesson | Q38156888 | ||
| Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins. | Q38202412 | ||
| The ubiquitin-conjugating system: multiple roles in viral replication and infection | Q38210024 | ||
| Herpes simplex virus type 2 UL56 interacts with the ubiquitin ligase Nedd4 and increases its ubiquitination | Q38610536 | ||
| Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression | Q38854742 | ||
| KSHV latent protein LANA2 inhibits sumo2 modification of p53. | Q38917974 | ||
| Recovery of an HMWP/hmwBP (pUL48/pUL47) complex from virions of human cytomegalovirus: subunit interactions, oligomer composition, and deubiquitylase activity | Q38994872 | ||
| Kaposi's sarcoma-associated herpesvirus lana2 protein interacts with the pocket proteins and inhibits their sumoylation. | Q39210824 | ||
| A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus | Q28259884 | ||
| Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012) | Q28263889 | ||
| Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity | Q28473623 | ||
| A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence | Q28477120 | ||
| A unique SUMO-2-interacting motif within LANA is essential for KSHV latency | Q28535343 | ||
| Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation | Q28535568 | ||
| The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth | Q28546003 | ||
| Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3 | Q28743826 | ||
| Ubiquitin-binding domains - from structures to functions | Q29614829 | ||
| Viruses and human cancers: a long road of discovery of molecular paradigms. | Q30384388 | ||
| A proteomic perspective of inbuilt viral protein regulation: pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection | Q30557071 | ||
| Functional interaction between human herpesvirus 6 immediate-early 2 protein and ubiquitin-conjugating enzyme 9 in the absence of sumoylation. | Q30827308 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies | Q33373662 | ||
| Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific | Q33648307 | ||
| The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi's sarcoma associated herpesvirus reactivation | Q33716143 | ||
| Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase | Q33826641 | ||
| Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes | Q33894274 | ||
| Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification | Q33908645 | ||
| Biphasic regulation of A20 gene expression during human cytomegalovirus infection | Q33925240 | ||
| SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes | Q33967953 | ||
| Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin | Q34013598 | ||
| Role of noncovalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth | Q34046161 | ||
| Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication | Q34059252 | ||
| Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity | Q34227708 | ||
| Characterization of human herpesvirus 6 variant B immediate-early 1 protein modifications by small ubiquitin-related modifiers | Q34315935 | ||
| Proteasome-Dependent Disruption of the E3 Ubiquitin Ligase Anaphase-Promoting Complex by HCMV Protein pUL21a | Q34335500 | ||
| Centromere architecture breakdown induced by the viral E3 ubiquitin ligase ICP0 protein of herpes simplex virus type 1. | Q34426987 | ||
| Herpesviruses and the microbiome | Q34682491 | ||
| The herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1. | Q34742340 | ||
| SUMO and KSHV Replication | Q34774847 | ||
| Itchy, a Nedd4 Ubiquitin Ligase, Downregulates Latent Membrane Protein 2A Activity in B-Cell Signaling | Q34975783 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88 | Q34992629 | ||
| KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasome | Q35116456 | ||
| SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication | Q35123249 | ||
| Autocatalytic activity of the ubiquitin-specific protease domain of herpes simplex virus 1 VP1-2. | Q35192778 | ||
| EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation | Q35224422 | ||
| Inhibition of RIG-I-Mediated Signaling by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Deubiquitinase ORF64 | Q35275001 | ||
| A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses | Q35489050 | ||
| What Has the Study of the K3 and K5 Viral Ubiquitin E3 Ligases Taught Us about Ubiquitin-Mediated Receptor Regulation? | Q35506528 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP. | Q35635192 | ||
| K-bZIP Mediated SUMO-2/3 Specific Modification on the KSHV Genome Negatively Regulates Lytic Gene Expression and Viral Reactivation | Q35703276 | ||
| Analysis of the SUMO2 Proteome during HSV-1 Infection | Q35705640 | ||
| Post-Translational Modifications of Kaposi’s Sarcoma-Associated Herpesvirus Regulatory Proteins – SUMO and KSHV | Q35755464 | ||
| Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. | Q35856781 | ||
| LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1 | Q35861199 | ||
| The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation | Q35913878 | ||
| Epstein-Barr Virus Latent Membrane Protein 1 Regulates the Function of Interferon Regulatory Factor 7 by Inducing Its Sumoylation | Q36363843 | ||
| Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step | Q36498260 | ||
| Role of RNF4 in the Ubiquitination of Rta of Epstein-Barr Virus | Q36812436 | ||
| Viral E3 ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA domain | Q36828487 | ||
| SUMO junction-what's your function? New insights through SUMO-interacting motifs | Q36839119 | ||
| Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression | Q36869463 | ||
| Recognition of herpesviruses by the innate immune system | Q36939781 | ||
| Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. | Q36949619 | ||
| The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. | Q37116670 | ||
| The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity. | Q37157230 | ||
| Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. | Q37252761 | ||
| Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase | Q37317681 | ||
| Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1. | Q37336427 | ||
| Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10. | Q37336832 | ||
| Interplay between poxviruses and the cellular ubiquitin/ubiquitin-like pathways | Q37378752 | ||
| Sumoylation and human disease pathogenesis | Q37413787 | ||
| Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation | Q37424480 | ||
| Cleavage specificity of the UL48 deubiquitinating protease activity of human cytomegalovirus and the growth of an active-site mutant virus in cultured cells | Q37452085 | ||
| Viral avoidance and exploitation of the ubiquitin system. | Q37464765 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 435-445 | |
| P577 | publication date | 2016-08-22 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Reviews in Medical Virology | Q15766137 |
| P1476 | title | Manipulation of ubiquitin/SUMO pathways in human herpesviruses infection | |
| P478 | volume | 26 |
| Q90597043 | Asparagine Deprivation Causes a Reversible Inhibition of Human Cytomegalovirus Acute Virus Replication |
| Q90505741 | Small molecules that target the ubiquitin system |
| Q39381317 | Structure and Function of Viral Deubiquitinating Enzymes. |
| Q38728203 | The Linear Ubiquitin Assembly Complex Modulates Latent Membrane Protein 1 Activation of NF-κB and Interferon Regulatory Factor 7. |
Search more.